Home/Filings/4/0001415889-24-025537
4//SEC Filing

MOORE ALISON 4

Accession 0001415889-24-025537

CIK 0001817241other

Filed

Oct 21, 8:00 PM ET

Accepted

Oct 22, 8:18 PM ET

Size

5.5 KB

Accession

0001415889-24-025537

Insider Transaction Report

Form 4
Period: 2024-10-21
MOORE ALISON
Director
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2024-10-21+27,50027,500 total
    Exercise: $10.48Exp: 2034-10-20Common Stock (27,500 underlying)
Footnotes (1)
  • [F1]One-third of the shares vested following the grant date, with the remaining shares vesting monthly over an additional two years following October 21, 2024,

Issuer

Artiva Biotherapeutics, Inc.

CIK 0001817241

Entity typeother

Related Parties

1
  • filerCIK 0001754937

Filing Metadata

Form type
4
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 8:18 PM ET
Size
5.5 KB